Chengdu Jiafaantai Education Technology (300559.SZ) controlling shareholder and shareholder De Yuantai plan to transfer a total of 5.8% of the company's shares to Quanyi Fund for a total price of 163 million yuan.

19:55 24/09/2024

Jiafa Education (300559.SZ) announces that the company's controlling shareholder and actual controller Yuan Bin, who holds more than 5% of the shares...

Chengdu Jiafaantai Education Technology (300559.SZ) announced that the company's controlling shareholder and actual controller Yuan Bin, and shareholder with more than 5% of the shares, Tibet De Yuan Tai Information Technology Co., Ltd. (referred to as "De Yuan Tai") signed a "Stock Transfer Agreement" with Quan Yida Private Equity Fund Management (Nanjing) Co., Ltd. (representing Quan Yida Sesame Blossom 1 Private Equity Securities Investment Fund) (referred to as "Quan Yida Fund") on September 23, 2024. Through the agreement, Yuan Bin and De Yuan Tai plan to transfer a total of 23.17 million shares (5.8% of the company's total shares) of Chengdu Jiafaantai Education Technology to Quan Yida Fund by way of transfer. The transfer price is 7.03 yuan per share, with a total transfer price of 163 million yuan.

Citigroup: Initiates 30-day upward catalyst observation on LUK FOOK HOLD (00590) Target price increased to 35.2 Hong Kong dollars.

HK Stock Market Move | Cssc Offshore & Marine Engineering (00317) rose over 6%, and the global new ship order volume in the second half of last year saw a significant increase in growth rate.

HK Stock Market Move | Minimally Invasive Heartflow-B (02160) continues to rise by over 10%, with a nearly 350% year-on-year growth in the annual implantation volume of TAVI products.

Citigroup: Initiates 30-day upward catalyst observation on LUK FOOK HOLD (00590) Target price increased to 35.2 Hong Kong dollars.

HK Stock Market Move | Cssc Offshore & Marine Engineering (00317) rose over 6%, and the global new ship order volume in the second half of last year saw a significant increase in growth rate.

HK Stock Market Move | Minimally Invasive Heartflow-B (02160) continues to rise by over 10%, with a nearly 350% year-on-year growth in the annual implantation volume of TAVI products.